Export for Central America contemplated

Published: 2002-04-17 06:56:00

Updated: 2002-04-17 06:56:00

Stimulated by the active market opening to foreign competition by several countries in the Central and South America, the domestic pharmaceutical industry plans to expand their presence there, in that those countries were implementing a variety of embargo policies on foreign drugs for the protect...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK